The forces shaping the obesity drugs industry
ANALYSIS: A university student’s perspective on what's fuelling the lucrative uptake of obesity medications, and what its long-term success hinges on.
Daniel Song
Sat, 21 Jun 2025
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Analysts predict the global market for obesity drugs to increase by 10 to 15 times to between US$95 and US$150 billion by 2030. This explosion mirrors the 12-fold increase in worldwide smartphone sales between 2007 and 2017.
Unlike technology hardware, this market is fuelled not just by innovation
Want to read more? It's easy.
Choose your subscription
Already have an account? Login
Smartphone Only Subscription
NZ$29.95 / monthly
Subscribe Now
Monthly Premium Online Subscription
NZ$49.95 / monthly
Subscribe Now
Smartphone Only Annual Subscription
NZ$299.00 / yearly
Subscribe Now
Yearly Premium Online Subscription
NZ$499.00 / yearly
Subscribe Now
Premium Group Membership 10 Users
NZ$385+GST / monthly
$38.5 per user - Pay by monthly
credit card debit
Subscribe Now
Premium Group Membership 20 Users
NZ$660+GST / monthly
$33 per user - Pay by monthly
credit card debit
Subscribe Now
Premium Group Membership 50 Users
NZ$1375+GST / monthly
$27.5 per user - Pay by monthly
credit card debit
Subscribe Now
Premium Group Membership 100 Users
NZ$2100+GST / monthly
$21 per user - Pay by monthly
credit card debit
Subscribe Now
Yearly Premium Online Subscription + NBR Marketplace
NZ$999.00 / yearly
Subscribe Now
Individual
Group membership
NBR Marketplace
Student
Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
Daniel Song
Sat, 21 Jun 2025
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
